- Seals/Symbols
- cGMP inspected facility
Good Manufacturing Practice
Proudly packaged in the U.S.A.
- FDA Statement of Identity
- Dietary Supplement
- Brand IP Statement(s) re: (c), (TM), (SM)
- CQR-300 is a registered trademark of Gateway Health Alliances, Inc. US patent 7,175,859 and international patents
IGOB 131 is a registered trademark of Gateway Health Alliances, Inc. US patent 7,537,790 and international patents
- FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- Precautions re: All Other
- Warning: Never exceed recommended serving
- Precautions re: Children
- Keep out of reach of children. Not for use by persons under age 18.
- Precautions re: Pregnant or Nursing or Prescription Medications
- Do not use if pregnant or nursing.
- Precautions re: All Other
- Do not consume synephrine or caffeine from other sources, including but not limited to, coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine. Product contains 150 mg of caffeine per capsule. Do not consume more than 1 capsule every 3-4 hours. Do not use if sensitive to caffeine. Consult your physician prior to use if you have a medical condition, including but not limited to, heart, liver, kidney, or thyroid disease, psychiatric disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Discontinue 2 weeks prior to surgery or if you experience rapid heartbeat, dizziness, severe headaches or shortness of breath. As individuals vary so may results from using this product. Do not exceed four (4) capsules per day. This product should be used in conjunction with proper diet and exercise.
- Precautions re: Pregnant or Nursing or Prescription Medications